Characterizing Cardiovascular Outcomes in Subclinical Primary Aldosteronism

亚临床原发性醛固酮增多症的心血管结局特征

• 批准号: 433253
• 负责人: Hundemer Gregory
• 金额: $ 32.32万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-10-01 至 2023-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=433253&lang=en
• 关键词: Aldosterone; Cardiovascular Disease; Conn'S Syndrome; Hypertension; Primary Aldosteronism; Primary Hyperaldosteronism; Renin

Background: Hypertension (high blood pressure) management generally involves a 'one size fits all' approach. Employing a more personalized approach targeting the cause of an individual patient's hypertension provides the opportunity to improve long-term h

背景：高血压管理通常涉及“一刀切”的方法。针对个体患者高血压的原因采用更加个性化的方法提供了改善长期健康状况的机会。